{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T15:15:46Z","timestamp":1780413346436,"version":"3.54.1"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Beijing Major Epidemic Prevention and Control Key Specialty Intensive Care Medicine Construction Project under Grant","award":["010086"],"award-info":[{"award-number":["010086"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antonie van Leeuwenhoek"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10482-026-02331-9","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T04:19:43Z","timestamp":1778127583000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Research advancement on the correlation between gut microbiota and chronic kidney disease"],"prefix":"10.1007","volume":"119","author":[{"given":"Rui","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaiqi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"issue":"1","key":"2331_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-42706-w","volume":"13","author":"S Ariyanopparut","year":"2023","unstructured":"Ariyanopparut S, Metta K, Avihingsanon Y et al (2023) The role of a low protein diet supplemented with ketoanalogues on kidney progression in pre-dialysis chronic kidney disease patients. Sci Rep 13(1):15459. https:\/\/doi.org\/10.1038\/s41598-023-42706-w","journal-title":"Sci Rep"},{"issue":"8","key":"2331_CR2","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3390\/nu16081109","volume":"16","author":"GY Arteaga-Muller","year":"2024","unstructured":"Arteaga-Muller GY, Flores-Trevi\u00f1o S, Bocanegra-Ibarias P et al (2024) Changes in the progression of chronic kidney disease in patients undergoing fecal microbiota transplantation. Nutrients 16(8):1109. https:\/\/doi.org\/10.3390\/nu16081109","journal-title":"Nutrients"},{"key":"2331_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/toxins12120741","author":"C Barba","year":"2020","unstructured":"Barba C, Soulage CO, Caggiano G et al (2020) Effects of fecal microbiota transplantation on composition in mice with CKD. Toxins (Basel). https:\/\/doi.org\/10.3390\/toxins12120741","journal-title":"Toxins (Basel)"},{"issue":"26","key":"2331_CR4","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1182\/blood.2019001675","volume":"134","author":"M Belghasem","year":"2019","unstructured":"Belghasem M, Roth D, Richards S et al (2019) Metabolites in a mouse cancer model enhance venous thrombogenicity through the aryl hydrocarbon receptor-tissue factor axis. Blood 134(26):2399\u20132413. https:\/\/doi.org\/10.1182\/blood.2019001675","journal-title":"Blood"},{"issue":"1","key":"2331_CR5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1053\/j.jrn.2019.01.004","volume":"30","author":"A Biruete","year":"2020","unstructured":"Biruete A, Hill Gallant KM, Lindemann SR et al (2020) Phosphate binders and nonphosphate effects in the gastrointestinal tract. J Ren Nutr 30(1):4\u201310. https:\/\/doi.org\/10.1053\/j.jrn.2019.01.004","journal-title":"J Ren Nutr"},{"key":"2331_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jnutbio.2018.02.011","volume":"56","author":"Y Chen","year":"2018","unstructured":"Chen Y, Xu C, Huang R et al (2018) Butyrate from pectin fermentation inhibits intestinal cholesterol absorption and attenuates atherosclerosis in apolipoprotein E-deficient mice. J Nutr Biochem 56:175\u2013182. https:\/\/doi.org\/10.1016\/j.jnutbio.2018.02.011","journal-title":"J Nutr Biochem"},{"key":"2331_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/toxins12110684","author":"TH Cheng","year":"2020","unstructured":"Cheng TH, Ma MC, Liao MT et al (2020) Indoxyl Sulfate, a tubular toxin, contributes to the development of chronic kidney disease. Toxins (Basel). https:\/\/doi.org\/10.3390\/toxins12110684","journal-title":"Toxins (Basel)"},{"issue":"5","key":"2331_CR8","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.cell.2016.10.043","volume":"167","author":"MS Desai","year":"2016","unstructured":"Desai MS, Seekatz AM, Koropatkin NM et al (2016) A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell 167(5):1339-1353.e21. https:\/\/doi.org\/10.1016\/j.cell.2016.10.043","journal-title":"Cell"},{"issue":"7","key":"2331_CR9","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1681\/ASN.2011121175","volume":"23","author":"F Duranton","year":"2012","unstructured":"Duranton F, Cohen G, De Smet R et al (2012) Normal and pathologic concentrations of uremic toxins. J Am Soc Nephrol 23(7):1258\u20131270. https:\/\/doi.org\/10.1681\/ASN.2011121175","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2331_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","volume":"19","author":"Y Fan","year":"2021","unstructured":"Fan Y, Pedersen O (2021) Gut microbiota in human metabolic health and disease. Nat Rev Microbiol 19(1):55\u201371. https:\/\/doi.org\/10.1038\/s41579-020-0433-9","journal-title":"Nat Rev Microbiol"},{"issue":"6","key":"2331_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/cti.2016.36","volume":"5","author":"RJ Felizardo","year":"2016","unstructured":"Felizardo RJ, Castoldi A, Andrade-Oliveira V et al (2016) The microbiota and chronic kidney diseases: a double-edged sword. Clin Transl Immunology 5(6):e86. https:\/\/doi.org\/10.1038\/cti.2016.36","journal-title":"Clin Transl Immunology"},{"issue":"10225","key":"2331_CR12","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"GBD Chronic Kidney Disease Collaboration","year":"2020","unstructured":"GBD Chronic Kidney Disease Collaboration (2020) Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 395(10225):709\u2013733. https:\/\/doi.org\/10.1016\/S0140-6736(20)30045-3","journal-title":"Lancet"},{"issue":"6","key":"2331_CR13","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1093\/ndt\/gfab004","volume":"36","author":"G Glorieux","year":"2021","unstructured":"Glorieux G, Vanholder R, Van Biesen W et al (2021) Free p-cresyl sulfate shows the highest association with cardiovascular outcome in chronic kidney disease. Nephrol Dial Transplant 36(6):998\u20131005. https:\/\/doi.org\/10.1093\/ndt\/gfab004","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"2331_CR14","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.kint.2020.01.028","volume":"97","author":"T Gryp","year":"2020","unstructured":"Gryp T, De Paepe K, Vanholder R et al (2020) Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease. Kidney Int 97(6):1230\u20131242. https:\/\/doi.org\/10.1016\/j.kint.2020.01.028","journal-title":"Kidney Int"},{"key":"2331_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001892.pub5","volume":"10","author":"D Hahn","year":"2020","unstructured":"Hahn D, Hodson EM, Fouque D (2020) Low protein diets for non-diabetic adults with chronic kidney disease. Cochrane Database Syst Rev 10:CD001892. https:\/\/doi.org\/10.1002\/14651858.CD001892.pub5","journal-title":"Cochrane Database Syst Rev"},{"key":"2331_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/nu14061171","author":"I Hamad","year":"2022","unstructured":"Hamad I, Cardilli A, C\u00f4rte-Real BF et al (2022) High-salt diet induces depletion of lactic acid-producing bacteria in murine gut. Nutrients. https:\/\/doi.org\/10.3390\/nu14061171","journal-title":"Nutrients"},{"issue":"1","key":"2331_CR17","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12967-024-04974-6","volume":"22","author":"M He","year":"2024","unstructured":"He M, Wei W, Zhang Y et al (2024) Gut microbial metabolites SCFAs and chronic kidney disease. J Transl Med 22(1):172. https:\/\/doi.org\/10.1186\/s12967-024-04974-6","journal-title":"J Transl Med"},{"issue":"6","key":"2331_CR18","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/00325481.2020.1744335","volume":"132","author":"X Hu","year":"2020","unstructured":"Hu X, Ouyang S, Xie Y et al (2020) Characterizing the gut microbiota in patients with chronic kidney disease. Postgrad Med 132(6):495\u2013505. https:\/\/doi.org\/10.1080\/00325481.2020.1744335","journal-title":"Postgrad Med"},{"key":"2331_CR19","doi-asserted-by":"publisher","unstructured":"Iwashima T, Takemura Y, Kishimoto Y, et al. (2024) Natural antagonistic flavones for AhR inhibit indoxyl sulfate-induced inflammatory gene expression in vitro and renal pathological damages in vivo. Food Nutr Res 68. https:\/\/doi.org\/10.29219\/fnr.v68.10032","DOI":"10.29219\/fnr.v68.10032"},{"issue":"4","key":"2331_CR20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1159\/000493862","volume":"48","author":"A Jadoon","year":"2018","unstructured":"Jadoon A, Mathew AV, Byun J et al (2018) Gut microbial product predicts cardiovascular risk in chronic kidney disease patients. Am J Nephrol 48(4):269\u2013277. https:\/\/doi.org\/10.1159\/000493862","journal-title":"Am J Nephrol"},{"issue":"10","key":"2331_CR21","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1007\/s10482-016-0737-y","volume":"109","author":"S Jiang","year":"2016","unstructured":"Jiang S, Xie S, Lv D et al (2016) A reduction in the butyrate producing species Roseburia spp. and Faecalibacterium prausnitzii is associated with chronic kidney disease progression. Antonie Van Leeuwenhoek 109(10):1389\u20131396. https:\/\/doi.org\/10.1007\/s10482-016-0737-y","journal-title":"Antonie Van Leeuwenhoek"},{"key":"2331_CR22","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.921557","volume":"26","author":"S Jiang","year":"2020","unstructured":"Jiang S, Wang B, Sha T et al (2020) Changes in the intestinal microbiota in patients with stage 5 chronic kidney disease on a low-protein diet and the effects of human to rat fecal microbiota transplantation. Med Sci Monit 26:e921557. https:\/\/doi.org\/10.12659\/MSM.921557","journal-title":"Med Sci Monit"},{"key":"2331_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/nu12071931","author":"K Kalantar-Zadeh","year":"2020","unstructured":"Kalantar-Zadeh K, Joshi S, Schlueter R et al (2020) Plant-dominant low-protein diet for conservative management of chronic kidney disease. Nutrients. https:\/\/doi.org\/10.3390\/nu12071931","journal-title":"Nutrients"},{"key":"2331_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.01623","volume":"9","author":"M Karbowska","year":"2018","unstructured":"Karbowska M, Kaminski TW, Znorko B et al (2018) Indoxyl sulfate promotes arterial thrombosis in rat model via increased levels of complex TF\/VII, PAI-1, platelet activation as well as decreased contents of SIRT1 and SIRT3. Front Physiol 9:1623. https:\/\/doi.org\/10.3389\/fphys.2018.01623","journal-title":"Front Physiol"},{"key":"2331_CR25","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.freeradbiomed.2018.01.007","volume":"116","author":"Y Ke","year":"2018","unstructured":"Ke Y, Li D, Zhao M et al (2018) Gut flora-dependent metabolite trimethylamine-N-oxide accelerates endothelial cell senescence and vascular aging through oxidative stress. Free Radic Biol Med 116:88\u2013100. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.01.007","journal-title":"Free Radic Biol Med"},{"issue":"4S","key":"2331_CR26","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2024) KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 105(4S):S117\u2013S314. https:\/\/doi.org\/10.1016\/j.kint.2023.10.018","journal-title":"Kidney Int"},{"issue":"5","key":"2331_CR27","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1038\/s41423-020-00625-0","volume":"18","author":"CH Kim","year":"2021","unstructured":"Kim CH (2021) Control of lymphocyte functions by gut microbiota-derived short-chain fatty acids. Cell Mol Immunol 18(5):1161\u20131171. https:\/\/doi.org\/10.1038\/s41423-020-00625-0","journal-title":"Cell Mol Immunol"},{"issue":"4","key":"2331_CR28","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.molcel.2020.03.005","volume":"78","author":"A Koh","year":"2020","unstructured":"Koh A, B\u00e4ckhed F (2020) From association to causality: the role of the gut microbiota and its functional products on host metabolism. Mol Cell 78(4):584\u2013596. https:\/\/doi.org\/10.1016\/j.molcel.2020.03.005","journal-title":"Mol Cell"},{"issue":"12","key":"2331_CR29","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/s41579-019-0256-8","volume":"17","author":"AA Kolodziejczyk","year":"2019","unstructured":"Kolodziejczyk AA, Zheng D, Elinav E (2019) Diet-microbiota interactions and personalized nutrition. Nat Rev Microbiol 17(12):742\u2013753. https:\/\/doi.org\/10.1038\/s41579-019-0256-8","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"2331_CR30","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.kint.2022.06.025","volume":"102","author":"L Koppe","year":"2022","unstructured":"Koppe L, Soulage CO (2022) The impact of dietary nutrient intake on gut microbiota in the progression and complications of chronic kidney disease. Kidney Int 102(4):728\u2013739. https:\/\/doi.org\/10.1016\/j.kint.2022.06.025","journal-title":"Kidney Int"},{"key":"2331_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/nu17233663","author":"PP Lagod","year":"2025","unstructured":"Lagod PP, Qasem A, Naser SA (2025) Short chain fatty acids lower inflammation and restore intestinal integrity and function markers in Mycobacterium paratuberculosis-infection in vitro model. Nutrients. https:\/\/doi.org\/10.3390\/nu17233663","journal-title":"Nutrients"},{"issue":"1","key":"2331_CR32","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000519603","volume":"47","author":"Y Lai","year":"2022","unstructured":"Lai Y, Tang H, Zhang X et al (2022) Trimethylamine-N-oxide aggravates kidney injury via activation of p38\/MAPK signaling and upregulation of HuR. Kidney Blood Press Res 47(1):61\u201371. https:\/\/doi.org\/10.1159\/000519603","journal-title":"Kidney Blood Press Res"},{"issue":"6S","key":"2331_CR33","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1053\/j.jrn.2022.12.004","volume":"33","author":"K Lambert","year":"2023","unstructured":"Lambert K, Rinninella E, Biruete A et al (2023) Targeting the gut microbiota in kidney disease: the future in renal nutrition and metabolism. J Ren Nutr 33(6S):S30\u2013S39. https:\/\/doi.org\/10.1053\/j.jrn.2022.12.004","journal-title":"J Ren Nutr"},{"issue":"4","key":"2331_CR34","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3390\/toxins12040229","volume":"12","author":"G Lano","year":"2020","unstructured":"Lano G, Burtey S, Sall\u00e9e M (2020) Indoxyl sulfate, a uremic endotheliotoxin. Toxins (Basel) 12(4):229. https:\/\/doi.org\/10.3390\/toxins12040229","journal-title":"Toxins (Basel)"},{"issue":"5","key":"2331_CR35","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1042\/CS20171107","volume":"132","author":"WL Lau","year":"2018","unstructured":"Lau WL, Savoj J, Nakata MB et al (2018) Altered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins. Clin Sci Lond 132(5):509\u2013522. https:\/\/doi.org\/10.1042\/CS20171107","journal-title":"Clin Sci Lond"},{"key":"2331_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1298432","volume":"15","author":"V Lazarevic","year":"2024","unstructured":"Lazarevic V, Teta D, Pruijm M et al (2024) Gut microbiota associations with chronic kidney disease: Insights into nutritional and inflammatory parameters. Front Microbiol 15:1298432. https:\/\/doi.org\/10.3389\/fmicb.2024.1298432","journal-title":"Front Microbiol"},{"issue":"6","key":"2331_CR37","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1161\/HYPERTENSIONAHA.115.06417","volume":"67","author":"M Levi","year":"2016","unstructured":"Levi M (2016) Role of bile acid-regulated nuclear receptor FXR and G protein-coupled receptor TGR5 in regulation of cardiorenal syndrome (cardiovascular disease and chronic kidney disease). Hypertension 67(6):1080\u20131084. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.115.06417","journal-title":"Hypertension"},{"issue":"1","key":"2331_CR38","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s13300-020-00952-5","volume":"12","author":"Q Li","year":"2021","unstructured":"Li Q, Wen F, Wang Y et al (2021) Diabetic kidney disease benefits from intensive low-protein diet: updated systematic review and meta-analysis. Diabetes Ther 12(1):21\u201336. https:\/\/doi.org\/10.1007\/s13300-020-00952-5","journal-title":"Diabetes Ther"},{"key":"2331_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/toxins13020142","author":"YJ Lim","year":"2021","unstructured":"Lim YJ, Sidor NA, Tonial NC et al (2021) Uremic toxins in the progression of chronic kidney disease and cardiovascular disease: mechanisms and therapeutic targets. Toxins (Basel). https:\/\/doi.org\/10.3390\/toxins13020142","journal-title":"Toxins (Basel)"},{"issue":"3","key":"2331_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0283389","volume":"18","author":"W Liu","year":"2023","unstructured":"Liu W, Huang J, Liu T et al (2023) Changes in gut microbial community upon chronic kidney disease. PLoS ONE 18(3):e0283389. https:\/\/doi.org\/10.1371\/journal.pone.0283389","journal-title":"PLoS ONE"},{"key":"2331_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2024.1434613","volume":"11","author":"C Liu","year":"2024","unstructured":"Liu C, Yang L, Wei W et al (2024) Efficacy of probiotics\/synbiotics supplementation in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials. Front Nutr 11:1434613. https:\/\/doi.org\/10.3389\/fnut.2024.1434613","journal-title":"Front Nutr"},{"issue":"6510","key":"2331_CR42","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1126\/science.abb3763","volume":"369","author":"L Lobel","year":"2020","unstructured":"Lobel L, Cao YG, Fenn K et al (2020) Diet posttranslationally modifies the mouse gut microbial proteome to modulate renal function. Science 369(6510):1518\u20131524. https:\/\/doi.org\/10.1126\/science.abb3763","journal-title":"Science"},{"key":"2331_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.579386","volume":"11","author":"D Luo","year":"2021","unstructured":"Luo D, Zhao W, Lin Z et al (2021) The effects of hemodialysis and peritoneal dialysis on the gut microbiota of end-stage renal disease patients, and the relationship between gut microbiota and patient prognoses. Front Cell Infect Microbiol 11:579386. https:\/\/doi.org\/10.3389\/fcimb.2021.579386","journal-title":"Front Cell Infect Microbiol"},{"key":"2331_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115143","volume":"250","author":"A Luxenburger","year":"2023","unstructured":"Luxenburger A, Harris LD, Ure EM et al (2023) The discovery of 12\u03b2-methyl-17-epi-18-nor-bile acids as potent and selective TGR5 agonists. Eur J Med Chem 250:115143. https:\/\/doi.org\/10.1016\/j.ejmech.2023.115143","journal-title":"Eur J Med Chem"},{"key":"2331_CR45","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-981-13-8871-2_1","volume":"1165","author":"JC Lv","year":"2019","unstructured":"Lv JC, Zhang LX (2019) Prevalence and disease burden of chronic kidney disease. Adv Exp Med Biol 1165:3\u201315. https:\/\/doi.org\/10.1007\/978-981-13-8871-2_1","journal-title":"Adv Exp Med Biol"},{"issue":"10","key":"2331_CR46","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.2217\/fmb.13.103","volume":"8","author":"D Mafra","year":"2013","unstructured":"Mafra D, Barros AF, Fouque D (2013) Dietary protein metabolism by gut microbiota and its consequences for chronic kidney disease patients. Future Microbiol 8(10):1317\u20131323. https:\/\/doi.org\/10.2217\/fmb.13.103","journal-title":"Future Microbiol"},{"key":"2331_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/toxins15080499","author":"D Mafra","year":"2023","unstructured":"Mafra D, Kemp JA, Borges NA et al (2023) Gut microbiota interventions to retain residual kidney function. Toxins (Basel). https:\/\/doi.org\/10.3390\/toxins15080499","journal-title":"Toxins (Basel)"},{"key":"2331_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23105354","author":"G Magliocca","year":"2022","unstructured":"Magliocca G, Mone P, Di Iorio BR et al (2022) Short-chain fatty acids in chronic kidney disease: focus on inflammation and oxidative stress regulation. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23105354","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2331_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/toxins10060226","volume":"10","author":"RD Mair","year":"2018","unstructured":"Mair RD, Sirich TL, Meyer TW (2018) Uremic toxin clearance and cardiovascular toxicities. Toxins (Basel) 10(6):226. https:\/\/doi.org\/10.3390\/toxins10060226","journal-title":"Toxins (Basel)"},{"issue":"8","key":"2331_CR50","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41577-024-01014-8","volume":"24","author":"ER Mann","year":"2024","unstructured":"Mann ER, Lam YK, Uhlig HH (2024) Short-chain fatty acids: linking diet, the microbiome and immunity. Nat Rev Immunol 24(8):577\u2013595. https:\/\/doi.org\/10.1038\/s41577-024-01014-8","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"2331_CR51","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1053\/j.jrn.2018.08.008","volume":"29","author":"C McFarlane","year":"2019","unstructured":"McFarlane C, Ramos CI, Johnson DW et al (2019) Prebiotic, probiotic, and synbiotic supplementation in chronic kidney disease: a systematic review and meta-analysis. J Ren Nutr 29(3):209\u2013220. https:\/\/doi.org\/10.1053\/j.jrn.2018.08.008","journal-title":"J Ren Nutr"},{"issue":"3","key":"2331_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25030594","volume":"25","author":"MD Pieczynska","year":"2020","unstructured":"Pieczynska MD, Yang Y, Petrykowski S et al (2020) Gut microbiota and its metabolites in atherosclerosis development. Molecules 25(3):594. https:\/\/doi.org\/10.3390\/molecules25030594","journal-title":"Molecules"},{"issue":"5","key":"2331_CR53","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1681\/ASN.2015030279","volume":"27","author":"R Poesen","year":"2016","unstructured":"Poesen R, Windey K, Neven E et al (2016) The influence of CKD on colonic microbial metabolism. J Am Soc Nephrol 27(5):1389\u20131399. https:\/\/doi.org\/10.1681\/ASN.2015030279","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2331_CR54","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1080\/19490976.2015.1127483","volume":"7","author":"JM Ridlon","year":"2016","unstructured":"Ridlon JM, Harris SC, Bhowmik S et al (2016) Consequences of bile salt biotransformations by intestinal bacteria. Gut Microbes 7(1):22\u201339. https:\/\/doi.org\/10.1080\/19490976.2015.1127483","journal-title":"Gut Microbes"},{"issue":"12","key":"2331_CR55","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1038\/s41564-022-01267-w","volume":"7","author":"W Santus","year":"2022","unstructured":"Santus W, Rana AP, Devlin JR et al (2022) Mycobiota and diet-derived fungal xenosiderophores promote Salmonella gastrointestinal colonization. Nat Microbiol 7(12):2025\u20132038. https:\/\/doi.org\/10.1038\/s41564-022-01267-w","journal-title":"Nat Microbiol"},{"issue":"7","key":"2331_CR56","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1681\/ASN.2014010042","volume":"26","author":"G Schulman","year":"2015","unstructured":"Schulman G, Berl T, Beck GJ et al (2015) Randomized placebo-controlled EPPIC trials of AST-120 in CKD. J Am Soc Nephrol 26(7):1732\u20131746. https:\/\/doi.org\/10.1681\/ASN.2014010042","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"2331_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1002533","volume":"14","author":"R Sender","year":"2016","unstructured":"Sender R, Fuchs S, Milo R (2016) Revised estimates for the number of human and bacteria cells in the body. PLoS Biol 14(8):e1002533. https:\/\/doi.org\/10.1371\/journal.pbio.1002533","journal-title":"PLoS Biol"},{"issue":"1","key":"2331_CR58","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/jim-2020-001715","volume":"70","author":"Y Sun","year":"2022","unstructured":"Sun Y, Zhou C, Chen Y et al (2022) Quantitative increase in short-chain fatty acids, especially butyrate protects kidney from ischemia\/reperfusion injury. J Investig Med 70(1):29\u201335. https:\/\/doi.org\/10.1136\/jim-2020-001715","journal-title":"J Investig Med"},{"key":"2331_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.850014","volume":"9","author":"J Tan","year":"2022","unstructured":"Tan J, Zhou H, Deng J et al (2022) Effectiveness of microecological preparations for improving renal function and metabolic profiles in patients with chronic kidney disease. Front Nutr 9:850014. https:\/\/doi.org\/10.3389\/fnut.2022.850014","journal-title":"Front Nutr"},{"issue":"14","key":"2331_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21145088","volume":"21","author":"JZ Tayyeb","year":"2020","unstructured":"Tayyeb JZ, Popeijus HE, Mensink RP et al (2020) Short-chain fatty acids (except hexanoic acid) lower NF-kB transactivation, which rescues inflammation-induced decreased apolipoprotein A-I transcription in HepG2 cells. Int J Mol Sci 21(14):5088. https:\/\/doi.org\/10.3390\/ijms21145088","journal-title":"Int J Mol Sci"},{"key":"2331_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2023.117344","volume":"387","author":"CJ Teunis","year":"2023","unstructured":"Teunis CJ, Stroes E, Boekholdt SM et al (2023) Tryptophan metabolites and incident cardiovascular disease: the EPIC-Norfolk prospective population study. Atherosclerosis 387:117344. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.117344","journal-title":"Atherosclerosis"},{"issue":"11","key":"2331_CR62","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1042\/BCJ20160510","volume":"474","author":"E Thursby","year":"2017","unstructured":"Thursby E, Juge N (2017) Introduction to the human gut microbiota. Biochem J 474(11):1823\u20131836. https:\/\/doi.org\/10.1042\/BCJ20160510","journal-title":"Biochem J"},{"key":"2331_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12051948","author":"L Voroneanu","year":"2023","unstructured":"Voroneanu L, Burlacu A, Brinza C et al (2023) Gut microbiota in chronic kidney disease: from composition to modulation towards better outcomes-a systematic review. J Clin Med. https:\/\/doi.org\/10.3390\/jcm12051948","journal-title":"J Clin Med"},{"issue":"5","key":"2331_CR64","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s13238-018-0549-0","volume":"9","author":"Z Wang","year":"2018","unstructured":"Wang Z, Zhao Y (2018) Gut microbiota derived metabolites in cardiovascular health and disease. Protein Cell 9(5):416\u2013431. https:\/\/doi.org\/10.1007\/s13238-018-0549-0","journal-title":"Protein Cell"},{"issue":"7341","key":"2331_CR65","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature09922","volume":"472","author":"Z Wang","year":"2011","unstructured":"Wang Z, Klipfell E, Bennett BJ et al (2011) Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472(7341):57\u201363. https:\/\/doi.org\/10.1038\/nature09922","journal-title":"Nature"},{"issue":"1","key":"2331_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-022-01443-4","volume":"11","author":"H Wang","year":"2023","unstructured":"Wang H, Ainiwaer A, Song Y et al (2023) Perturbed gut microbiome and fecal and serum metabolomes are associated with chronic kidney disease severity. Microbiome 11(1):3. https:\/\/doi.org\/10.1186\/s40168-022-01443-4","journal-title":"Microbiome"},{"issue":"7682","key":"2331_CR67","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nature24628","volume":"551","author":"N Wilck","year":"2017","unstructured":"Wilck N, Matus MG, Kearney SM et al (2017) Salt-responsive gut commensal modulates TH17 axis and disease. Nature 551(7682):585\u2013589. https:\/\/doi.org\/10.1038\/nature24628","journal-title":"Nature"},{"issue":"3","key":"2331_CR68","doi-asserted-by":"publisher","first-page":"420","DOI":"10.7150\/ijbs.37421","volume":"16","author":"IW Wu","year":"2020","unstructured":"Wu IW, Lin CY, Chang LC et al (2020a) Gut microbiota as diagnostic tools for mirroring disease progression and circulating nephrotoxin levels in chronic kidney disease: Discovery and validation study. Int J Biol Sci 16(3):420\u2013434. https:\/\/doi.org\/10.7150\/ijbs.37421","journal-title":"Int J Biol Sci"},{"key":"2331_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/nu12092799","author":"IW Wu","year":"2020","unstructured":"Wu IW, Lee CC, Hsu HJ et al (2020b) Compositional and functional adaptations of intestinal microbiota and related metabolites in CKD patients receiving dietary protein restriction. Nutrients. https:\/\/doi.org\/10.3390\/nu12092799","journal-title":"Nutrients"},{"issue":"1","key":"2331_CR70","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1038\/s41598-017-01387-y","volume":"7","author":"KY Xu","year":"2017","unstructured":"Xu KY, Xia GH, Lu JQ et al (2017) Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients. Sci Rep 7(1):1445. https:\/\/doi.org\/10.1038\/s41598-017-01387-y","journal-title":"Sci Rep"},{"issue":"8","key":"2331_CR71","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1007\/s00394-024-03494-9","volume":"63","author":"X Xu","year":"2024","unstructured":"Xu X, Hu J, Pang X et al (2024) Association between plant and animal protein and biological aging: findings from the UK Biobank. Eur J Nutr 63(8):3119\u20133132. https:\/\/doi.org\/10.1007\/s00394-024-03494-9","journal-title":"Eur J Nutr"},{"key":"2331_CR72","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.yjmcc.2019.07.004","volume":"134","author":"W Yang","year":"2019","unstructured":"Yang W, Zhang S, Zhu J et al (2019) Gut microbe-derived metabolite trimethylamine N-oxide accelerates fibroblast-myofibroblast differentiation and induces cardiac fibrosis. J Mol Cell Cardiol 134:119\u2013130. https:\/\/doi.org\/10.1016\/j.yjmcc.2019.07.004","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"2331_CR73","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2169\/internalmedicine.1602-23","volume":"63","author":"T Yasuno","year":"2024","unstructured":"Yasuno T, Takahashi K, Tada K et al (2024) Dysbiosis of gut microbiota in patients with chronic kidney disease. Intern Med 63(3):347\u2013352. https:\/\/doi.org\/10.2169\/internalmedicine.1602-23","journal-title":"Intern Med"},{"key":"2331_CR74","doi-asserted-by":"publisher","unstructured":"Zeng Y, Guo M, Wu Q, et al. (2024) Gut microbiota-derived indole-3-propionic acid alleviates diabetic kidney disease through its mitochondrial protective effect via reducing ubiquitination mediated-degradation of SIRT1. J Adv Res :S2090\u20131232(24)00361\u201300368 [pii]. https:\/\/doi.org\/10.1016\/j.jare.2024.08.018","DOI":"10.1016\/j.jare.2024.08.018"},{"issue":"1","key":"2331_CR75","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1080\/0886022X.2021.1936038","volume":"43","author":"J Zhao","year":"2021","unstructured":"Zhao J, Bai M, Yang X et al (2021) Alleviation of refractory IgA nephropathy by intensive fecal microbiota transplantation: the first case reports. Ren Fail 43(1):928\u2013933. https:\/\/doi.org\/10.1080\/0886022X.2021.1936038","journal-title":"Ren Fail"},{"issue":"4","key":"2331_CR76","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1080\/10408398.2020.1740645","volume":"61","author":"HJ Zheng","year":"2021","unstructured":"Zheng HJ, Guo J, Wang Q et al (2021) Probiotics, prebiotics, and synbiotics for the improvement of metabolic profiles in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr 61(4):577\u2013598. https:\/\/doi.org\/10.1080\/10408398.2020.1740645","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"2","key":"2331_CR77","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s13730-020-00560-z","volume":"10","author":"G Zhou","year":"2021","unstructured":"Zhou G, Zeng J, Peng L et al (2021) Fecal microbiota transplantation for membranous nephropathy. CEN Case Rep 10(2):261\u2013264. https:\/\/doi.org\/10.1007\/s13730-020-00560-z","journal-title":"CEN Case Rep"},{"issue":"10","key":"2331_CR78","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1016\/j.cmet.2021.06.014","volume":"33","author":"H Zhu","year":"2021","unstructured":"Zhu H, Cao C, Wu Z et al (2021) The probiotic L. casei Zhang slows the progression of acute and chronic kidney disease. Cell Metab 33(10):1926-1942.e8. https:\/\/doi.org\/10.1016\/j.cmet.2021.06.014","journal-title":"Cell Metab"}],"container-title":["Antonie van Leeuwenhoek"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10482-026-02331-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10482-026-02331-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10482-026-02331-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T14:55:04Z","timestamp":1780412104000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10482-026-02331-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":78,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2331"],"URL":"https:\/\/doi.org\/10.1007\/s10482-026-02331-9","relation":{},"ISSN":["0003-6072","1572-9699"],"issn-type":[{"value":"0003-6072","type":"print"},{"value":"1572-9699","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"22 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"120"}}